Sleeve Gastrectomy with duodenojejunal End-to-Side anastomosis in the treatment of type 2 diabetes mellitus: the initial experiences in a chinese population with a more than 4-year follow-up

Gastric bypass has been supposed to be associated with a risk of gastric cancer, particularly in Asia. Sleeve gastrectomy with duodenojejunal end-to-side anastomosis (SG-DJESA) was suggested to be a better designed procedure to avoid this risk, and it also has other advantages. We aimed to evaluate the clinical efficacy and feasibility of SG-DJESA in the treatment of non-obese patients with type 2 diabetes mellitus (T2D).
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Source Type: research